The Cooper Companies, Inc. (NASDAQ:COO) Holdings Lifted by Lord Abbett & CO. LLC

Lord Abbett & CO. LLC grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 251,402 shares of the medical device company’s stock after buying an additional 14,957 shares during the period. Lord Abbett & CO. LLC’s holdings in Cooper Companies were worth $27,740,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. LRI Investments LLC increased its position in Cooper Companies by 4.5% in the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after acquiring an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC increased its holdings in shares of Cooper Companies by 1.5% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock valued at $881,000 after purchasing an additional 117 shares during the period. Commonwealth Equity Services LLC raised its stake in shares of Cooper Companies by 0.8% during the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after purchasing an additional 118 shares in the last quarter. Bleakley Financial Group LLC lifted its stake in shares of Cooper Companies by 2.1% in the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock worth $636,000 after acquiring an additional 119 shares during the period. Finally, First Horizon Advisors Inc. lifted its position in Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after purchasing an additional 125 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.9 %

Shares of NASDAQ COO opened at $94.85 on Monday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The business has a 50-day moving average price of $103.49 and a two-hundred day moving average price of $98.97. The firm has a market capitalization of $18.93 billion, a PE ratio of 48.64, a PEG ratio of 2.52 and a beta of 0.97.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period last year, the company posted $0.87 earnings per share. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of a number of research analyst reports. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Piper Sandler increased their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Insider Activity

In related news, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.